These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2311333)

  • 1. Polymorphism in hydroxylation of mephenytoin and hexobarbital stereoisomers in relation to hepatic P-450 human-2.
    Yasumori T; Murayama N; Yamazoe Y; Kato R
    Clin Pharmacol Ther; 1990 Mar; 47(3):313-22. PubMed ID: 2311333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9).
    Kato R; Yamazoe Y; Yasumori T
    Xenobiotica; 1992; 22(9-10):1083-92. PubMed ID: 1441599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation.
    Knodell RG; Dubey RK; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1988 Jun; 245(3):845-9. PubMed ID: 3385644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo.
    Meier UT; Dayer P; Malè PJ; Kronbach T; Meyer UA
    Clin Pharmacol Ther; 1985 Nov; 38(5):488-94. PubMed ID: 4053486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of a rat liver cytochrome P-450 induced by pregnenolone 16 alpha-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin.
    Shimada T; Guengerich FP
    Mol Pharmacol; 1985 Aug; 28(2):215-9. PubMed ID: 4022003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in stereoselective metabolism of mephenytoin by cytochrome P450 (CYP2C and CYP3A).
    Yasumori T; Chen L; Nagata K; Yamazoe Y; Kato R
    J Pharmacol Exp Ther; 1993 Jan; 264(1):89-94. PubMed ID: 8423554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and polymorphism of human P-450 which activates and detoxicates xenobiotics and carcinogens.
    Kato R; Yamazoe Y; Yasumori T
    Princess Takamatsu Symp; 1990; 21():45-53. PubMed ID: 2134689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition of hexobarbital and its metabolites: relationship to the S-mephenytoin polymorphism in Caucasian and Chinese subjects.
    Adedoyin A; Prakash C; O'Shea D; Blair IA; Wilkinson GR
    Pharmacogenetics; 1994 Feb; 4(1):27-38. PubMed ID: 8004130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation.
    Gut J; Meier UT; Catin T; Meyer UA
    Biochim Biophys Acta; 1986 Dec; 884(3):435-47. PubMed ID: 3096378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CYP2C19 in stereoselective hydroxylation of mephobarbital by human liver microsomes.
    Kobayashi K; Kogo M; Tani M; Shimada N; Ishizaki T; Numazawa S; Yoshida T; Yamamoto T; Kuroiwa Y; Chiba K
    Drug Metab Dispos; 2001 Jan; 29(1):36-40. PubMed ID: 11124227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-mephenytoin 4-hydroxylase is inherited as an autosomal-recessive trait in Japanese families.
    Ward SA; Goto F; Nakamura K; Jacqz E; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1987 Jul; 42(1):96-9. PubMed ID: 3595072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation.
    Yasumori T; Li QH; Yamazoe Y; Ueda M; Tsuzuki T; Kato R
    Pharmacogenetics; 1994 Dec; 4(6):323-31. PubMed ID: 7704038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae.
    Brian WR; Srivastava PK; Umbenhauer DR; Lloyd RS; Guengerich FP
    Biochemistry; 1989 Jun; 28(12):4993-9. PubMed ID: 2669966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.
    Shimada T; Misono KS; Guengerich FP
    J Biol Chem; 1986 Jan; 261(2):909-21. PubMed ID: 3079764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A methodological investigation on the estimation of the S-mephenytoin hydroxylation phenotype using the urinary S/R ratio.
    Tybring G; Bertilsson L
    Pharmacogenetics; 1992 Oct; 2(5):241-3. PubMed ID: 1306124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency.
    Meier UT; Meyer UA
    Biochemistry; 1987 Dec; 26(25):8466-74. PubMed ID: 3442670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
    Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.